Health

The House of Commons Standing Committee on Health met to discuss several topics, including supplementary budget estimates, the Canadian Dental Care Plan, and safe drug consumption sites. Minister of Health Marjorie Michel answered questions about funding for various health initiatives, such as the National Consensus Conference on Hemovigilance, naloxone distribution in Indigenous communities, and a measles prevention campaign. She also spoke about the government's focus on men's health and the toxic drug crisis, emphasizing the need for community-based solutions. Committee members questioned the Minister on a range of issues. There was a lot of discussion about the effectiveness and safety of supervised drug consumption sites, with some members citing a study suggesting that closing a consumption site did not increase deaths. The Minister defended the sites as life-saving measures, while others argued for a focus on addiction treatment and recovery. There were also questions about the Canadian Dental Care Plan, including concerns about laboratory fees and patient eligibility. The Minister and department officials committed to providing written responses to several questions. Later in the meeting, committee members debated a motion to compel the production of documents related to the Canadian Dental Care Plan, safe consumption sites, and other health programs. The debate became heated, with accusations of obstruction and filibustering. An amendment to the motion was proposed but ultimately withdrawn. The committee also discussed the closure of a Canadian Food Inspection Agency laboratory in Longueuil, with officials assuring members that the closure would not affect food safety or scientific capacity. The meeting was adjourned before a final decision on the motion could be reached.

The House of Commons Standing Committee on Health met to discuss Canada's pharmaceutical sovereignty. The committee heard from several witnesses representing pharmaceutical companies and research institutions. The discussion covered topics such as domestic drug manufacturing, supply chain security, regulatory processes, and innovation in the pharmaceutical sector. Jeff Watson from Apotex emphasized the importance of domestic generic pharmaceutical manufacturing and urged the government to prioritize this sector in its "buy Canadian" policy. Michel Bouvier, a professor at the Université de Montréal, highlighted the need for local innovation and development of new therapies, emphasizing the IRIC-IRICoR model as an example of how innovation infrastructure can contribute to pharmaceutical sovereignty. Julian Somers, a clinical psychologist, raised concerns about addiction policies and potential conflicts of interest in the pharmaceutical industry. Jim Keon from the Canadian Generic Pharmaceutical Association stressed that cost-saving generic and biosimilar medicines are strategic assets and called for addressing barriers to market entry for these medicines. Terry Creighton from the Canadian Pharmaceutical Manufacturers and Exporters Alliance advocated for strengthening domestic drug manufacturing and proposed a five-point action plan. Bettina Hamelin from Innovative Medicines Canada warned that Canada's access to new medicines is at risk and called for strategic action to strengthen pharmaceutical sovereignty. During the meeting, committee members questioned witnesses on various issues, including the role of pharmaceutical companies in the opioid crisis, the impact of government policies on domestic manufacturing, and the need for regulatory reforms. A motion was introduced to summon a representative from Grifols, a pharmaceutical company, to testify before the committee. The committee agreed to include the Grifols representative as part of a panel of witnesses for one hour.

The House of Commons Standing Committee on Health met to discuss a proposed law to create a Living Donor Recognition Medal. This medal would honor Canadians who donate organs, blood, or bone marrow to save lives. Ziad Aboultaif, a Member of Parliament who donated part of his liver to his son, presented the proposed law. He emphasized the importance of raising awareness about organ donation and thanked committee members for their support. Christopher McCreery, an expert on the Canadian honors system, also spoke, raising concerns about including post-nominal letters after the medal, arguing it doesn't fit within the existing honors system and could diminish recognition for military members. During the meeting, committee members discussed the details of the proposed law and considered amendments. They talked about who should be eligible for the medal, including blood donors, and how the medal should be awarded. Some members raised concerns about comparing blood donation to organ donation, as organ donation involves a greater physical risk. However, others argued that long-term blood donors also deserve recognition for their commitment to saving lives. The committee ultimately agreed to several amendments to the proposed law. These changes broadened eligibility for the medal to include blood and bone marrow donors, and clarified the process for awarding the medal. The committee decided that the Governor General could award the medal to non-Canadians if the donation occurred within the Canadian health system. They also removed a clause mandating public ceremonies for the medal presentation. After making these changes, the committee approved the proposed law as amended. The next step is for the proposed law to go back to the House of Commons for a third reading. If it passes there, it will then go to the Senate for consideration. The committee also approved a modified work plan for a study on Canada's pharmaceutical sovereignty. Overall, the meeting was productive, with committee members working together to improve the proposed law and move it forward in the legislative process. The goal is to create a meaningful way to recognize and encourage life-saving donations in Canada.

The Health Committee met to discuss the Interim Federal Health Program (IFHP), which provides temporary health coverage to certain foreign nationals. The committee reviewed a report from the Parliamentary Budget Officer (PBO) projecting the program's costs. Jason Jacques, Interim Parliamentary Budget Officer, presented the report, highlighting that IFHP costs could reach $1.5 billion by 2030. Committee members questioned the PBO team about the program's rising costs, eligibility criteria, and potential for abuse. Dan Mazier (Conservative) raised concerns about the program's rapid growth and the inclusion of supplemental benefits for asylum seekers, even those with rejected claims or facing serious charges. Doug Eyolfson (Liberal) inquired about the impact of proposed co-payments and the potential long-term cost savings of providing early treatment. Maxime Blanchette-Joncas (Bloc Québécois) questioned the program's administrative capacity and the allocation of funding between provinces. Several committee members expressed interest in a more detailed analysis of the program, including the impact of proposed changes, a breakdown of supplemental benefits, and the financial sensitivity to processing times. A motion was introduced to request an updated report from the PBO with further in-depth analysis. After much debate and several amendments, the committee approved a motion requesting an updated report from the PBO and inviting the PBO, the Minister of Health, the Minister of Immigration, Refugees and Citizenship, and officials from both departments to testify before the committee. The committee also agreed to a budget for an upcoming meeting and discussed the order of future business. A motion was passed outlining the committee's upcoming work, including a study on pharmaceutical sovereignty and consideration of a proposed law.

The Health Committee met to discuss the $20 million loss of medical supplies from the National Emergency Strategic Stockpile (NESS). Committee members wanted to know how the loss happened and what steps are being taken to prevent it from happening again. Representatives from the Public Health Agency of Canada (PHAC), including Nancy Hamzawi (President) and Stacey Mantha (Director General), answered questions about the incident. They explained that the loss was due to a system error in the quality management system and that they have since made changes to improve monitoring and security. Committee members questioned why no one was held accountable for the loss and whether Canada is prepared for another health emergency. PHAC representatives assured the committee that the stockpile has been restocked and that Canada is better prepared now than before the pandemic. They highlighted increased staffing, funding, and storage space for the NESS. They also mentioned ongoing collaboration with other countries and industries to improve best practices and learn from past incidents. Members also raised concerns about contracts with PPE suppliers potentially linked to forced labor and the government's rationale for continuing to do business with suppliers that failed to deliver during the pandemic. PHAC representatives committed to providing written responses to several questions, including details on PPE contracts, the country of origin of a foreign actor who attempted to access the warehouse, and the impact of defunding the Canadian Consortium for Clinical Trial Training. The committee also discussed the role of the NESS in responding to the 2025 forest fires and the importance of diversifying vaccine supply sources.

The House of Commons Standing Committee on Health met to discuss health-related aspects of the 2025 budget and a proposed law to improve sharing of health information. The Minister of Health, Marjorie Michel, presented the government's plans, including investments in health infrastructure, research, and biomanufacturing. She highlighted a proposed law aimed at creating a more connected health care system, allowing for better access to personal health information for Canadians and health professionals. Committee members questioned the minister on various topics, including supervised drug consumption sites, the Canadian dental care plan, and vaccine production. Officials from Health Canada and related agencies were present to provide additional information and support to the minister. During the meeting, Dan Mazier (Conservative) questioned the Minister about a supervised drug consumption site near a child care facility in Ottawa. He asked why the permit for the site was renewed despite safety concerns raised by law enforcement. The Minister defended the decision, stating that the approval process involves multiple factors and that Health Canada had worked with the site to implement stricter measures. Helena Jaczek (Liberal) inquired about the Canadian dental care plan, and the Minister reported that millions of Canadians have enrolled and received care, with a wide range of oral health professionals participating in the program. Maxime Blanchette-Joncas (Bloc Québécois) questioned the Minister about investments in health infrastructure and vaccine production, expressing concerns about the adequacy of funding and the lack of domestic vaccine production capacity. Later in the meeting, committee members questioned Health Canada officials on topics such as age requirements at supervised consumption sites, funding for harm reduction programs, and the progress of the vaccine injury support program. Kendal Weber, Assistant Deputy Minister, clarified that Health Canada does not set age limits for access to supervised consumption sites and that the sites are intended to provide support and prevent overdoses. Nancy Hamzawi, President of the Public Health Agency of Canada, provided updates on the vaccine injury support program, noting that thousands of claims have been submitted and that payments have been made to eligible claimants. The committee also discussed a proposed law to amend the Human Pathogens and Toxins Act, with officials explaining that the changes are needed to address evolving biosecurity risks and strengthen oversight of the biomanufacturing sector. Paul Hébert, President of the Canadian Institutes for Health Research, spoke about the potential of the connected care proposed law to improve health care delivery and support research and innovation. He emphasized the importance of data sharing and interoperability to enable better clinical trials, personalized treatment, and system planning. Kimby Barton, Director General of the Centre for Biosecurity, discussed the motivation behind the amendments to the Human Pathogens and Toxins Act, citing factors such as increased investment in biomanufacturing and an evolving threat landscape. The committee agreed to extend the deadline for public submissions on antimicrobial resistance to March 15, 2026.

The House of Commons Standing Committee on Health met to discuss antimicrobial resistance (AMR) and strategies to combat it. Witnesses from academia, agriculture, and veterinary medicine shared their perspectives. They emphasized the need for a "one health" approach, recognizing the interconnectedness of human, animal, and environmental health. Key discussion points included improving surveillance of AMR, promoting responsible antimicrobial use, and addressing regulatory barriers to accessing veterinary medicines and alternative therapies. Speakers highlighted the importance of research and innovation, as well as the need for greater coordination and investment in AMR initiatives. Dr. Dao Nguyen from McGill University emphasized the urgency of the AMR crisis and the need for new solutions, including faster diagnostic tests and comprehensive surveillance systems. She also called for greater strategic funding for AMR research. Dr. Joseph Rubin from the University of Saskatchewan spoke about the fragmented knowledge of AMR in animals and the need for more data to support antimicrobial stewardship in companion animal practice. Dr. Scott Weese from the University of Guelph stressed the complexity of the issue and the need to consider animal and human health as separate but linked entities. Representatives from the Canadian Federation of Agriculture and the Canadian Pork Council discussed the efforts of farmers and veterinarians to promote responsible antimicrobial use and prevent infections. They also raised concerns about regulatory barriers to accessing veterinary health care tools. Dr. Tracy Fisher from the Canadian Veterinary Medical Association highlighted the importance of veterinary expertise in antimicrobial policy and drug regulatory development. She also expressed concern about proposed changes to the categorization of antimicrobials that could reduce access to important veterinary medicines. Committee members questioned the witnesses on various aspects of AMR, including the role of regulatory flexibility, the impact of antimicrobial use in animals on human health, and the effectiveness of different strategies for combating AMR. There was discussion about the need for better coordination and communication between different levels of government and sectors. The committee also explored potential solutions, such as improving access to vaccines and alternative therapies, and investing in research and surveillance. Several witnesses suggested that Canada needs an "antimicrobial resistance czar" to coordinate efforts and resources across sectors and jurisdictions. The committee agreed to table a white paper from the Canadian Federation of Agriculture that outlines barriers and solutions to improve access to veterinary health care tools. The committee will use the information gathered during the meeting to inform its report on antimicrobial resistance.

The House of Commons Standing Committee on Health met to discuss antimicrobial resistance (AMR), which happens when medicines stop working against infections. Experts shared their knowledge about the problem and what Canada can do. The committee heard from doctors, researchers, and a patient advocate. Dr. Isaac Bogoch talked about how most antibiotics worldwide are used in farm animals, not people. He said Canada needs to work with other countries to reduce antibiotic use in agriculture. Dr. Victor Leung said Canada is behind other countries in getting new antibiotics to people who need them. He also mentioned that the systems for tracking infections are not working well together. Dr. Karl Weiss said antibiotics are important for modern health care, but they are being overused. He also said Canada depends on other countries to make antibiotics. Dr. Gerry Wright talked about how Canada is losing researchers to other countries because there isn't enough funding for AMR research here. He suggested creating a program to help companies turn research into new medicines. Dr. Makeda Semret talked about how to use the antibiotics we have wisely. She said hospitals need to measure how well they are doing at preventing infections. Kim Neudorf, a patient advocate, shared a story about someone who died from an antibiotic-resistant infection. She asked the government to give money to patient groups and to teach people about AMR. The committee agreed to invite Governor-in-Council appointees serving in the Canadian Centre on Substance Abuse to a meeting before February 26, 2026.

The House of Commons Standing Committee on Health met to discuss spending estimates for various health-related agencies. Representatives from Health Canada, the Public Health Agency of Canada (PHAC), the Canadian Food Inspection Agency (CFIA), and the Canadian Institutes of Health Research (CIHR) presented their proposed budgets and answered questions from committee members. A significant portion of the discussion focused on Health Canada's funding of harm reduction programs, including the provision of drug paraphernalia like pipes, with some committee members questioning the effectiveness and appropriateness of such spending. There was also discussion regarding a $20 million loss of supplies from the national emergency stockpile, leading to a motion to have PHAC testify further on the matter in both public and private sessions. Greg Orencsak, Deputy Minister of Health, outlined Health Canada's proposed spending, including funds for the Canadian dental care plan and drug toxicity indicator harmonization. Nancy Hamzawi, President of PHAC, detailed the agency's request for funding, including money for pandemic vaccine preparedness. Robert Ianiro from the CFIA discussed investments in trade diversification and regulatory modernization. Jeff Moore, from CIHR, highlighted funding for health research, including projects related to school food programs and indigenous youth services. Kendal Weber, Assistant Deputy Minister at Health Canada, faced intense questioning regarding the department's funding of harm reduction supplies, particularly crack pipes and foil kits. She defended the funding as a response to the toxic drug crisis, while some committee members expressed concern about the use of taxpayer money for such purposes. Dr. Natasha Crowcroft, from PHAC, spoke about the public health benefits of harm reduction, including reducing the spread of infectious diseases. Committee members raised concerns about budget cuts at Health Canada and the National Microbiology Laboratory, as well as the quality of imported personal protective equipment. The committee also discussed the importance of antimicrobial resistance (AMR) surveillance and the need for a coordinated approach to address this issue. Dr. Charu Kaushic, from CIHR, emphasized the importance of collaboration and knowledge mobilization in AMR research. The committee agreed to invite the Minister of Health and department officials to testify before February 6, 2026. Additionally, following discussion of a $20 million loss of supplies from the national emergency stockpile, the committee passed a motion to invite the Public Health Agency of Canada to testify on the matter, with one hour of the testimony to be public and one hour to be held in camera by February 10, 2026.

The House of Commons Standing Committee on Health met to discuss antimicrobial resistance (AMR). Witnesses shared their expertise on the challenges and potential solutions to AMR in Canada. Dr. Judith Fafard highlighted the importance of monitoring antimicrobial resistance and the need for better data sharing between provinces and territories. She suggested exploring barriers that hinder surveillance programs and encouraging research on the economic and health impacts of resistant pathogens. Dr. Sameeh Salama emphasized that innovation is key to addressing AMR and called for the implementation and funding of the Pan-Canadian Action Plan on Antimicrobial Resistance. He also pointed out Canada's lack of domestic antibiotic manufacturing, posing a national security risk. Jennifer Buckley stressed that AMR is a present crisis, not a future threat, and that Canada needs a reliable system to bring innovative antibiotics to patients. She noted that regulatory and reimbursement processes in Canada are slow, delaying access to new antibiotics. The committee members questioned the witnesses on various aspects of AMR, including regional differences, over-prescription of antibiotics, and the role of surveillance. They also discussed potential solutions, such as improving laboratory capacity, harmonizing diagnostic methods, and increasing funding for research and healthcare. The witnesses emphasized the need for collaboration between industry, government, and academic researchers to address AMR effectively. The committee also discussed the challenges of getting witnesses the right equipment for virtual meetings and the importance of having the Minister of Health attend future meetings to discuss supplementary estimates. Ultimately, the committee agreed to continue its study of antimicrobial resistance and to invite Dr. Karl Weiss to a future meeting. The clerk was instructed to send another letter to the Minister of Health and the department, suggesting that the department could come to discuss estimates if the minister cannot make it. The committee also acknowledged the importance of addressing the regulatory and reimbursement processes to improve access to new antibiotics for Canadians.

The House of Commons Standing Committee on Health met to discuss antimicrobial resistance (AMR). The committee heard from several experts who spoke about different aspects of the issue. Scot Magnish from ATMIS talked about problems with the quality and sourcing of personal protective equipment (PPE), particularly isolation gowns, and how this impacts infection control. He raised concerns about expired gowns in the national stockpile and reliance on imports from China, some of which may be made with forced labor. Dr. Rita Dhami from the Canadian Society of Healthcare-Systems Pharmacy emphasized the need for stronger national surveillance of resistant organisms, sustainable antimicrobial stewardship programs, and improved access to antimicrobial therapies. Dr. Kevin Stinson from Infection Prevention and Control Canada highlighted inconsistencies in infection prevention and control programs across the country and the need for better surveillance data. Dr. Sameer Elsayed from Western University discussed the global threat of AMR, the misuse and overuse of antimicrobials, and the need for expedited regulatory approval for new antimicrobials. Dr. Terry Wuerz from the Winnipeg Regional Health Authority spoke about the importance of antibiotics in modern medicine and the increasing rates of resistant infections. He stressed the need for funding and standardization of antimicrobial stewardship programs and rapid access to new antimicrobials. Committee members questioned the witnesses on various topics, including the management of the national strategic stockpile, the role of pharmacists in antimicrobial stewardship, and the use of antibiotics in agriculture. The committee agreed to invite the Minister of Health to testify on supplementary estimates at a future meeting. They also requested the Public Health Agency of Canada, Health Canada, Department of National Defence, and the Department of Public Services and Procurement to answer questions about the National Emergency Strategic Stockpile and PPE procurement within two weeks.

The House of Commons Standing Committee on Health met to discuss medical education and the challenges of recruiting and retaining healthcare professionals in Canada. The committee heard from Dr. Patricia Houston from the University of Toronto about the funding the university receives for training international medical graduates and how that money is used. Committee members questioned her about the ethics of accepting money from countries with poor human rights records and whether these foreign-funded positions were taking away opportunities from Canadian students. Dr. Houston explained that the international trainees do not take positions away from Canadian students and that the funding supports the university's education and research programs.

The House of Commons Standing Committee on Health met to discuss how immigration policies affect healthcare and the challenges faced by internationally trained health professionals. Witnesses from Health Canada and Immigration, Refugees and Citizenship Canada (IRCC) spoke about efforts to address healthcare worker shortages by integrating foreign-trained professionals into the Canadian system. Key points included streamlining immigration processes, recognizing foreign credentials, and supporting the integration of these professionals. The committee also heard about programs like Nova Scotia's Physician Assessment Centre of Excellence (PACE), which assesses and integrates foreign-trained doctors while providing care to underserved communities. The Association of Faculties of Medicine of Canada discussed increasing medical school training capacity and residency positions to address workforce shortages.

The House of Commons Standing Committee on Health met to discuss how immigration policies affect healthcare in Canada. The committee wanted to understand how to better integrate internationally trained health professionals into the Canadian healthcare system. They also discussed how to ensure that immigration levels match the country's healthcare capacity. The key speakers were the Minister of Health, Marjorie Michel, and the Minister of Immigration, Refugees and Citizenship, Lena Metlege Diab. Minister Michel talked about a new fund to help skilled immigrants get their credentials recognized faster, especially in healthcare. Minister Diab spoke about how immigration helps bring skilled health professionals to Canada and the importance of working with provinces and territories. Committee members questioned the ministers on various issues, such as whether immigration levels match healthcare capacity, how to prioritize licensing internationally trained doctors already in Canada, and the impact of temporary foreign worker programs. There was also discussion about the Interim Federal Health Program, which provides health coverage to refugees and asylum seekers. The committee voted on a motion to summon a representative from the University of Toronto's faculty of medicine to discuss the visa trainee program, where foreign-funded doctors train in Canadian hospitals but then return to their home countries. The motion passed, so the committee will ask the representative to appear at a future meeting.

The House of Commons Standing Committee on Health met to discuss the impact of immigration on healthcare and the challenges faced by internationally trained health professionals. The committee heard from representatives from the Canadian Physiotherapy Association, World Education Services, and Catholic Community Services of York Region. Speakers discussed the need for a streamlined process for recognizing the credentials of foreign-trained professionals, as well as the need to increase the number of training spots for healthcare workers in Canada. Krissy Bell from the Canadian Physiotherapy Association highlighted the growing number of internationally educated physiotherapists in Canada and the difficulties they face in getting licensed. She suggested funding programs to help with credential recognition and to encourage Canadians trained abroad to return home. Shamira Madhany from World Education Services emphasized the need for a national strategy to coordinate immigration, credential recognition, and labor market planning. She proposed a coordinating body to streamline licensing pathways and develop national standards. Dr. Ali Amiri and Dr. Antanina Hulko from Catholic Community Services of York Region shared their personal experiences as international medical graduates. They spoke about the barriers they face in getting licensed and the frustration of not being able to contribute to the Canadian healthcare system. Dr. Hulko described a new policy in Ontario that restricts eligibility for residency programs based on where applicants attended high school, which she felt was unfair. Committee members discussed potential solutions, such as creating a national licensing system, increasing training capacity, and providing more support for internationally trained professionals. There was a general agreement that the current system is not working effectively and that changes are needed to address the healthcare workforce shortage. The committee agreed to a one-week extension for the supplementary report for the women's health study.

The House of Commons Standing Committee on Health met to discuss the impact of immigration policies on healthcare, focusing on integrating internationally trained professionals. The committee heard from Martin Johansen, the mayor of Oliver, B.C., who spoke about the challenges rural communities face in recruiting and retaining doctors, leading to frequent emergency room closures. He suggested making it easier for international medical graduates and Canadians studying abroad to practice in rural areas where they are needed most. Jodi Hall, CEO of the Canadian Association for Long Term Care, discussed workforce shortages in long-term care and how immigration policies could help. She proposed simplifying immigration pathways for healthcare workers and prioritizing their applications. Both Johansen and Hall supported a national licensure system to allow healthcare workers to move freely between provinces. During the question period, committee members explored potential solutions to healthcare staffing shortages. Helena Konanz (Conservative) questioned Mayor Johansen about the emergency room closures in Oliver and the lack of notice given to residents. Doug Eyolfson (Liberal) asked about a pan-Canadian licensure system and its potential to help rural communities. Luc Thériault (Bloc Québécois) discussed the challenges of retaining nursing staff and the rise of private agencies due to poor working conditions in the public sector. Burton Bailey (Conservative) inquired whether the federal immigration department consulted with the Canadian Association for Long Term Care on this year's immigration plan, and Marcus Powlowski (Liberal) questioned the reliance on temporary foreign workers and the impact of recent restrictions. In the second hour, the committee heard from Deidre Lake, Executive Director of the Alberta International Medical Graduate Association, who spoke about the challenges internationally trained physicians face in getting licensed in Canada. She suggested pre-arrival competency assessments and streamlining the licensure process. Linda Silas, President of the Canadian Federation of Nurses Unions, and Baljinder Singh, a member of their advisory committee, discussed the barriers internationally educated nurses face, including fragmented licensure systems and lack of mentorship. Dr. Shazeen Suleman, a pediatrician, spoke about the need to ensure all children in Canada have equal access to healthcare, regardless of their immigration status. During the second question period, committee members continued to explore solutions to healthcare staffing shortages and the integration of internationally trained professionals. A motion was proposed and passed to have the Minister of Health and the Minister of Immigration, Refugees and Citizenship appear together for two hours to discuss the impact of immigration on healthcare. The committee also agreed to have a separate meeting with departmental officials and other witnesses.

The Canadian parliamentary committee on health met to discuss the impact of immigration on healthcare, focusing on the challenges faced by internationally trained healthcare professionals. Witnesses included Dr. Pantea Barati, a physician, and Dr. Valerie Grdisa, CEO of the Canadian Nurses Association, and later Dr. Andrew Padmos and Dr. Sandra Rao. Dr. Barati shared her personal struggles as an international medical graduate (IMG) in Canada, highlighting barriers to residency training and licensing, which led her to practice in the U.K. Dr. Grdisa emphasized the need for a streamlined, transparent, and competency-based approach to credential recognition for internationally educated nurses (IENs). Dr. Rao discussed the impact of population growth on acute care and the challenges of the current system. Dr. Padmos spoke about the Saudi visa training program and the benefits of the program to Saudi Arabia and the culture of the medical community in Saudi Arabia.

The House of Commons Standing Committee on Health met to discuss how immigration policies affect healthcare and the challenges faced by foreign-trained healthcare workers in Canada. Witnesses included a Canadian doctor trained abroad who couldn't get a residency, representatives from the Medical Council of Canada, and the Society of Canadians Studying Medicine Abroad. They talked about problems like confusing licensing rules, limited training spots, and foreign-trained doctors taking positions that could go to Canadians. Committee members discussed the need for clearer national standards, more support for foreign-trained healthcare workers already in Canada, and better coordination between immigration and healthcare planning. Dr. Scott Alexander shared his personal struggle to practice in Canada after studying medicine in Australia, highlighting the barriers and retroactive changes to exam requirements. Dr. Viren Naik from the Medical Council of Canada emphasized the need for modernizing standards and creating clear pathways for international medical graduates (IMGs). Rosemary Pawliuk and Dr. Douglas Munkley from the Society of Canadians Studying Medicine Abroad advocated for equal opportunities for Canadian medical students studying abroad and the removal of barriers to licensing. The committee questioned whether the federal immigration department consulted with the Medical Council of Canada on immigration levels or requested data on healthcare capacity. They also discussed concerns about foreign doctors training in Canada through visa programs and then returning to their home countries, while qualified Canadians struggle to find training spots. There was a suggestion to focus on licensing immigrant doctors already in Canada before bringing in more people. Witnesses suggested solutions such as national licensure recognition, reformed recency of practice requirements, and increased support for practice-ready assessments. They also discussed the need for better data collection and coordination between federal and provincial governments to address the challenges faced by foreign-trained healthcare workers. The committee explored the possibility of creating a federal website to help foreign graduates navigate the licensing process. Ultimately, the committee recognized the need for a multi-faceted approach to address the systemic constraints facing the Canadian healthcare system and to better integrate internationally trained health professionals into the workforce. No specific decisions were made, but the discussion highlighted the complexities of the issue and the need for further action.

The House of Commons Standing Committee on Health met to discuss how immigration policies affect healthcare and the challenges faced by internationally trained professionals in getting their credentials recognized in Canada. Witnesses included representatives from the Canadian Anesthesiologists' Society, the Canadian Association of Schools of Nursing, the Royal College of Physicians and Surgeons of Canada, the College of Family Physicians of Canada, the Federation of Medical Regulatory Authorities of Canada, and the Internationally Trained Physicians of Canada. They talked about the shortage of healthcare workers, especially in rural areas, and the difficulties faced by foreign-trained doctors and nurses in getting licensed to work in Canada. Key speakers like Dr. Giuseppe Fuda from the Canadian Anesthesiologists' Society highlighted the shortage of anesthesiologists and the need to simplify the licensing process for foreign-trained ones. Dr. Rani Srivastava from the Canadian Association of Schools of Nursing talked about the nursing shortage and the importance of helping foreign-trained nurses integrate into the Canadian healthcare system. Dr. Christopher Watling from the Royal College of Physicians and Surgeons of Canada suggested expanding practice-ready assessment programs and providing top-up training to help foreign-trained doctors meet Canadian standards. Dr. Therese Bichay from the Internationally Trained Physicians of Canada shared her personal struggles in getting her medical license recognized in Canada, despite being a qualified and experienced doctor. The committee discussed potential solutions such as creating national standards for assessing and licensing foreign-trained healthcare workers, providing financial support for training and assessment programs, and improving communication between immigration authorities and healthcare regulatory bodies. There was also talk about the need for better planning and coordination between the federal and provincial governments to address the healthcare workforce shortage. The committee members agreed that it is important to find ways to make it easier for qualified foreign-trained professionals to work in Canada, while still maintaining high standards of patient care. No specific decisions were made, but the committee will continue to study the issue and consider possible recommendations.